GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a prominent focus in medical studies, largely due to its notable impact on managing ailments such as second type diabetes and weight gain. Recent studies have demonstrated that in addition to glucose management, GLP-1 agonists offer potential for cardiovascular functi